Delivery Order SPE2DR25D2212-SPE2DR26FB9TY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed price contract valued at $9,799.56. The award, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on February 4, 2026, for the supply of Jardiance 10 mg tablets (90-count units) with a contract ceiling value of $4,516.15. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through full and open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of February 5,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 27, 2026, for the supply of Jardiance 10 mg tablets (90-count units) valued at $1,579.10, with an ultimate completion date of January 28, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's location in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Jardiance 10 mg tablets (90-count packages) with a contract ceiling value of $11,562.78. This is a firm fixed-price delivery order with an ultimate completion date of January 6, 2026, utilizing no set-aside designation and awarded through competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $10,494.63. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $4,967.99 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units), with an ultimate completion date of December 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical vendor. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $15,594.53 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) on January 20, 2026, with a completion date of January 21, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) under a firm fixed-price contract with a ceiling value of $23,332.53. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of November 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract valued at $50,049.62. The award, issued on December 19, 2025, is non-set-aside and competitively awarded, with an ultimate completion date of December 22, 2025. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $22,075.40. The award, made on November 12, 2025, with an ultimate completion date of November 13, 2025, represents a non-competitive delivery order issued without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performance location for this pharmaceutical supply...
- SPE2DR25D2212Indefinite Delivery Contract
- SPE2DR25D2212-SPE2DR26FB9TYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (quantity: 90) valued at $24,553.33 on February 3, 2026, with an ultimate completion date of February 4, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded on a full and open basis. The awardee, AmerisourceBergen Drug Corp, is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and is a subsidiary of Cencora, Inc. The place of performance is listed at the company's corporate office in Conshohocken, PA. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at up to $999.999 billion and extends through December 2026. This comprehensive contract vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including deliveries to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Jardiance, a diabetes medication, aligns with the IDC's therapeutic scope, which encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.6k | 2/2/26 |